Loading
AL
Awakn Life Sciences Corp. (1169082 BC Ltd.) Stock: price and insider trades · Canada
Awakn Life Sciences Corp. (1169082 BC Ltd.): what insiders have been doing
Awakn Life Sciences Corp. (1169082 BC Ltd.) is a listed company. Filings by its managers are published through SEDI. The past year has been quiet: not a single insider filing for Awakn Life Sciences Corp. (1169082 BC Ltd.). The previous disclosure was published on 27 November 2023.
The full history, which starts in 2021, counts 32 purchases against no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
52
Thresholds
n/a
Buy Volume
€111,693
32 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 27 November 2023
Declarations52 total
40,000 sharesCommon SharesTSXSEDI:4213714
Canonical exit: 20 Feb 2024 (T+90)
21,100 shares@ CA$0.08Common SharesTSXSEDI:4213123
Canonical exit: 19 Feb 2024 (T+90)
20,000 shares@ CA$0.07Common SharesTSXSEDI:4212738
Canonical exit: 18 Feb 2024 (T+90)
249,000 shares@ CA$0.06Common SharesTSXSEDI:4211777
Canonical exit: 15 Feb 2024 (T+90)
450,000 sharesCommon SharesTSXSEDI:4211069
Canonical exit: 15 Feb 2024 (T+90)
25,000 shares@ CA$0.55Common SharesTSXSEDI:4003904
60,000 shares@ CA$0.5541.9% of flowCommon SharesTSXSEDI:4002659
2,000 shares@ CA$0.631.3% of flowCommon SharesTSXSEDI:3965171
Canonical exit: 20 Sept 2022 (T+90)
8,500 shares@ CA$0.635.4% of flowCommon SharesTSXSEDI:3965170
Canonical exit: 19 Sept 2022 (T+90)
10,000 shares@ CA$0.555.6% of flowCommon SharesTSXSEDI:3962889
Canonical exit: 15 Sept 2022 (T+90)
500 shares@ CA$1.251.3% of flowCommon SharesTSXSEDI:3949926
Canonical exit: 22 Aug 2022 (T+90)
600 shares@ CA$1.261.6% of flowCommon SharesTSXSEDI:3949927
Canonical exit: 22 Aug 2022 (T+90)
400 shares@ CA$1.531.3% of flowCommon SharesTSXSEDI:3934493
Canonical exit: 19 Jul 2022 (T+90)
400 shares@ CA$1.531.3% of flowCommon SharesTSXSEDI:3933839
Canonical exit: 17 Jul 2022 (T+90)
500 shares@ CA$1.531.7% of flowCommon SharesTSXSEDI:3933838
Canonical exit: 17 Jul 2022 (T+90)
Common SharesTSXSEDI:3916226
31,250 shares@ CA$0.16100.0% of flowCommon SharesTSXSEDI:3916227
30,250 shares@ CA$1.60100.0% of flowCommon SharesTSXSEDI:3912136
15,600 shares@ CA$1.6052.8% of flowCommon SharesTSXSEDI:3912131
15,600 shares@ CA$1.6024.8% of flowCommon SharesTSXSEDI:3912134
Common SharesTSXSEDI:3874876
Common SharesTSXSEDI:3874846
1,000 shares@ CA$2.1353.3% of flowCommon SharesTSXSEDI:3874462
Canonical exit: 24 Apr 2022 (T+90)
2,125 shares@ CA$2.359426.2% of flowCommon SharesTSXSEDI:3874120
Canonical exit: 21 Apr 2022 (T+90)
1,000 shares@ CA$2.574.0% of flowCommon SharesTSXSEDI:3872167
Canonical exit: 19 Apr 2022 (T+90)
25 of 52 declarations
About Awakn Life Sciences Corp. (1169082 BC Ltd.)
Awakn Life Sciences Corp. is a Canadian company focused on developing substance-assisted psychotherapy treatments for mental health disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.
